Skip to content

A research study to find the effect of use of ice to prevent ulceration of mouth in patients receiving Chemotherapy and radiotherapy for head and Neck cancer

A randomized trial to assess the effect of Oral Cryotherapy in prevention of mucositis in head and neck cancer patients receiving Chemo-Radiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026657
Enrollment
128
Registered
2020-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention1: Cryotherapy with CTRT: Oral cryotherapy(ice cube or ice water or ice popsicles
5-7 times a day orally
Patient will have to keep the ice cubes during chemotherapy and before and after RT dose of the day)+ CTRT (As per NCCN guidelines) Control Intervention1: Only CTRT: Standard CT-RT(As per NCCN guideli

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 70-years Histologically or cytologically confirmed head and neck squamous cell carcinoma planned for Adjuvant CT-RT or Radical CT-RT ECOG PS 0-2 No underlying Mucositis at baseline No contraindication to oral intake(presence of ryles tube, risk for aspiration pneumonia, OCF) Willing to undergo study intervention(Oral-cryotherapy)

Exclusion criteria

Exclusion criteria: Decreased mouth opening causing difficulty in oral mucositis assessment Patients receiving radical chemoradiation in unresectable oral cavity cancer or post neoadjuvant chemotherapy Oral infections/Oral thrush at baseline Active medical co-morbidities Participating in any other trail that has oral mucositis as primary end point Dental complications preventing intake of cold beverages

Design outcomes

Primary

MeasureTime frame
Occurrence of Gr-3 to Gr-5 MucositisTimepoint: Baseline, weekly till end of CT-RT and 3 months post CT-RT

Secondary

MeasureTime frame
Compliance to definitive treatmentTimepoint: Weekly till end of definitive CT-RT;Cost incurredTimepoint: End of CT-RT;Quality of LifeTimepoint: Baseline and end of CT-RT

Countries

India

Contacts

Public ContactDr Nandini Menon

Tata Memorial Hospital

nandini.menon1412@gmail.com9769178270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 6, 2026